Condition

Pancreatic Acinar Cell Carcinoma clinical trials and research

• 2Clinical trials
• 3Countries

All recruiting trials (2)

• Using Olaparib to Prevent Recurrence in Patients with Resected Pancreatic Cancer and Specific Genetic Mutations

  This study is testing if the drug olaparib can help prevent pancreatic cancer from coming back in patients who have had surgery and specific genetic mutations.

  Recruiting at 261 sites Phase 2 National Cancer Institute (NCI) · Anchorage, Alaska and 455 other locations · NCT04858334

• Treatment for metastatic cancer with BRCA or PALB2 mutations using chemotherapy and stem cells

  This study is testing a new treatment combining chemotherapy and stem cells for people with metastatic pancreatic or breast cancer who have BRCA or PALB2 mutations to see if it is safe and effective.

  Recruiting Phase 1 General Oncology, Inc. · Boston, Massachusetts and 1 other locations · NCT04150042

Related topics

Quick answers

How many Pancreatic Acinar Cell Carcinoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (2 trials), Israel (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →